Dr Filipe Barata is a postdoctoral researcher at the Centre for Digital Health Interventions (CDHI) at ETH Zurich, where he serves as the Core Director for AI & Digital Biomarker, Acoustic and Inflammatory Biomarkers.
Filipe holds a diploma (M.Sc.) in electrical engineering and information technology and a PhD (Dr. Sc.) in applied machine Learning in healthcare from ETH Zurich. In his professional career he gained experience in several research laboratories, including the Department of Biomedical Data Science at the Geisel School of Medicine at Dartmouth College (USA), the research department of Bruker BioSpin, and the R&D department of LMS International (Siemens).
For his doctoral thesis entitled "Enabling a Digital Biomarker for Asthma – Smartphone Contact-Free Audio-based Nocturnal Cough Monitoring", he developed a smartphone-based system for monitoring cough in patients with asthma. This research led to two software publications, a patent and the founding of the startup Resmonics AG, which offers respiratory disease monitoring with clinically validated biomarkers.
In his research, he investigates the potential of mobile technologies such as wearable sensors, mobile applications, social media and location-tracking technologies for the monitoring and self-management of people with chronic diseases (also known in the relevant literature as “digital biomarkers”).
